Webb GJ, et al. - Experts coveted an elucidation of the rate and characteristics of rifampicin-induced hepatitis in a mixed aetiology cohort of patients with established liver disease and cholestatic pruritus. Findings suggested that adult patients, including those with jaundice, could be counselled regarding 95% of prescriptions being safe, and the drug cessation being effective where hepatitis occurred, including at long latency due to the efficacy of rifampicin for a significant sub-group of individuals with cholestatic pruritus.